[A case of SIADH due to pancreatic cancer was improved by tolvaptan].

Matsuyama, Sho; Ueo, Taro; Ozawa, Tomomi; Matsumoto, Atsushi; Minami, Ryuki; Kimura, Yuto; Takeda, Yasuhiro; Okano, Akihiro; Kusumi, Fusako; Ohana, Masaya

Matsuyama, Sho; Ueo, Taro; Ozawa, Tomomi; Matsumoto, Atsushi; Minami, Ryuki; Kimura, Yuto; Takeda, Yasuhiro; Okano, Akihiro; Kusumi, Fusako; Ohana, Masaya.

Affiliation

Matsuyama S; Department of Gastroenterology, Tenri Hospital.
Ueo T; Department of Gastroenterology, Tenri Hospital.
Ozawa T; Department of Gastroenterology, Tenri Hospital.
Matsumoto A; Department of Gastroenterology, Tenri Hospital.
Minami R; Department of Gastroenterology, Tenri Hospital.
Kimura Y; Department of Gastroenterology, Tenri Hospital.
Takeda Y; Department of Gastroenterology, Tenri Hospital.
Okano A; Department of Gastroenterology, Tenri Hospital.
Kusumi F; Department of Gastroenterology, Tenri Hospital.
Ohana M; Department of Gastroenterology, Tenri Hospital.

Nihon Shokakibyo Gakkai Zasshi ; 119(2): 172-178, 2022.

Article in Ja | MEDLINE | ID: mdl-35153267

Subject(s)

Inappropriate ADH Syndrome; Pancreatic Neoplasms; Aged; Antidiuretic Hormone Receptor Antagonists/therapeutic use; Benzazepines/therapeutic use; Humans; Inappropriate ADH Syndrome/drug therapy; Inappropriate ADH Syndrome/etiology; Male; Pancreatic Neoplasms/complications; Pancreatic Neoplasms/drug therapy; Quality of Life; Tolvaptan; Vasopressins

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Inappropriate ADH Syndrome Type of study: Etiology_studies / Prognostic_studies Aspects: Patient_preference Limits: Aged / Humans / Male Language: Ja Journal: Nihon Shokakibyo Gakkai Zasshi Year: 2022 Document type: Article Country of publication: Japan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google